Orchestra BioMed presents slide deck on AVIM, Virtue SAB programs
Orchestra BioMed disclosed a slide presentation outlining AVIM Therapy and Virtue SAB pivotal programs, strategic funding of more than $185 million and 2027 trial and commercialization milestones.